24 /100
LOW RISK
Score updated Jul 13, 2026

EYE — National Vision Holdings, Inc. Dilution Risk Tracker

Track EYE dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track EYE — Get alerts when the score changes →

As of July 13, 2026, National Vision Holdings, Inc. (EYE) has a DilutionWatch DilutionScore of 24/100, rated LOW dilution risk. National Vision Holdings, Inc. has a market capitalization of $1.34B, 80.12M shares outstanding, 260 institutional holders tracked. Key dilution vectors include approximately 999 months of cash runway.

Source: DilutionWatch (dilutionwatch.com) — data updated daily from SEC EDGAR filings. Not financial advice.

📊 Score Breakdown

📋 Offering Ability
40
💰 Cash Runway
0
📊 Float Risk
10
⚠️ Warrant Exposure
40
🔄Convertible Debt

🌦️ Dilution Forecast

☀️
Clear
No significant dilution signals
0%
No significant dilution signals detected for EYE.
🔔 Track EYE — Get forecast alerts →

💹 Market Data

Market Cap$1.34B
Shares Outstanding80.12M
Float78.10M
Cash$67.90M
Debt$233.29M
Short InterestN/A

🏛 Institutional Holdings

QoQ: ↑ 12.1% shares (2026Q1 vs prior)
260 institutional holders · 105.74M shares
#1 BlackRock, Inc. 11.54M shares
#2 VANGUARD CAPITAL MANAGEMENT LLC 6.88M shares
#3 VANGUARD PORTFOLIO MANAGEMENT LLC 5.75M shares
+ 17 more holders Sign up free to view →

📉 Short Interest

Short Interest16.57M
Days to Cover6.6
% of Float21.2%
FINRA data as of Jun 30, 2026

📁 Recent SEC Activity

No recent SEC insights

📰 Recent News

No recent news

📋 What This Means for EYE Shareholders

National Vision Holdings, Inc. (EYE) has a DilutionScore of 24/100, rated Low dilution risk. At this score level, DilutionWatch's real-time EDGAR monitoring shows limited near-term dilution signals. This does not mean zero dilution risk — shelf registrations can be filed and activated quickly — but the current filing profile shows no major outstanding dilution programs. Score as of July 13, 2026.

DilutionWatch's EDGAR monitoring for EYE shows no major active dilution programs at this time. The primary risk categories — shelf registration capacity, ATM programs, warrant overhang, and cash runway — are each within normal ranges for a company of this profile. This can change quickly if a new S-3 or Form S-1 is filed.

DilutionWatch tracks over 25 SEC filing types for EYE in real-time, scanning EDGAR every 60 seconds. The DilutionWatch screener shows real-time score changes for EYE alongside comparable low-risk stocks. Not financial advice — this analysis is for informational purposes only.

Track EYE Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking EYE — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required

🔗 Related Stocks — LOW Risk

Other LOW dilution risk stocks tracked by DilutionWatch with similar profiles:

Browse all 7,800+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
🔬 More Research for EYE
📊 EYE FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 EYE Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.